Dapagliflozin Improves Cardiac Hemodynamics and Mitigates Arrhythmogenesis in Mitral Regurgitation‐Induced Myocardial Dysfunction

BACKGROUND: Mitral regurgitation (MR) is a major contributor for heart failure (HF) and atrial fibrillation. Despite the advancement of MR surgeries, an effective medical therapy to mitigate MR progression is lacking. Sodium glucose cotransporter 2 inhibitors, a new class of antidiabetic drugs, has...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yu‐Wen, Chen, Chin‐Yu, Shih, Jhih‐Yuan, Cheng, Bor‐Chih, Chang, Ching‐Ping, Lin, Mao‐Tsun, Ho, Chung‐Han, Chen, Zhih‐Cherng, Fisch, Sudeshna, Chang, Wei‐Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174384/
https://www.ncbi.nlm.nih.gov/pubmed/33749310
http://dx.doi.org/10.1161/JAHA.120.019274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174384/
https://www.ncbi.nlm.nih.gov/pubmed/33749310
http://dx.doi.org/10.1161/JAHA.120.019274

Ejemplares similares